Back to Search Start Over

Latest preclinical study suggests broader potential utility of MDM2 antisense

Source :
Cancer Weekly. March 23, 2004, p52
Publication Year :
2004

Abstract

2004 MAR 23 - (NewsRx.com & NewsRx.net) -- Hybridon, Inc., (HBY) announced the publication of a preclinical research report presenting evidence in cells and cell lysates that the MDM2 oncoprotein [...]

Subjects

Subjects :
Hybridon Inc.

Details

Language :
English
ISSN :
15324567
Database :
Gale General OneFile
Journal :
Cancer Weekly
Publication Type :
News
Accession number :
edsgcl.114414866